MAM
ADPT icon

Martingale Asset Management’s Adaptive Biotechnologies ADPT Stock Holding History

Martingale Asset Management’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-25,145
Closed -$293K – 757
2025
Q2 		$293K Sell
25,145
-33,180
-57% -$301K 0.01% 709
2025
Q1 		$433K Sell
58,325
-296
-0.5% -$2.27K 0.01% 625
2024
Q4 		$351K Hold
58,621
– – 0.01% 662
2024
Q3 		$300K Buy
58,621
+21
+0% +$91 0.01% 709
2024
Q2 		$212K Sell
58,600
-108
-0.2% -$343 ﹤0.01% 752
2024
Q1 		$188K Hold
58,708
– – ﹤0.01% 784
2023
Q4 		$288K Buy
58,708
+3,900
+7% +$17.8K 0.01% 707
2023
Q3 		$299K Buy
54,808
+3,504
+7% +$23.2K 0.01% 685
2023
Q2 		$344K Sell
51,304
-4,200
-8% -$31.2K 0.01% 679
2023
Q1 		$490K Buy
55,504
+37
+0.1% +$326 0.01% 622
2022
Q4 		$424K Buy
55,467
+8,513
+18% +$66.2K 0.01% 653
2022
Q3 		$335K Buy
46,954
+20,554
+78% +$194K 0.01% 698
2022
Q2 		$214K Buy
+26,400
New +$232K ﹤0.01% 799

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
AAP
Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Martingale Asset Management's ADPT Position: Q3 2025 in Review

Martingale Asset Management sold out of Adaptive Biotechnologies (ADPT) in Q3 2025, closing a stake of 25,145 shares — an estimated $293K sold.

Martingale Asset Management first reported a position in ADPT in Q2 2022 and held it in 13 quarters. The position peaked at $490K in Q1 2023. 271 funds tracked by Wall St. Rank hold ADPT as of Q3 2025.

  • Martingale Asset Management reported no remaining Adaptive Biotechnologies position as of Q3 2025 after selling out during the quarter.
  • Martingale Asset Management sold 25,145 Adaptive Biotechnologies shares in Q3 2025, an estimated $293K.
  • Martingale Asset Management first reported a position in Adaptive Biotechnologies in Q2 2022 and held it in 13 quarters.
  • Martingale Asset Management's Adaptive Biotechnologies position peaked at $490K in Q1 2023.
  • 271 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2025.

Based on Martingale Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.